Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02730312
Title PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Xencor, Inc.
Indications

chronic myeloid leukemia

acute myeloid leukemia

B-cell acute lymphoblastic leukemia

Therapies

XmAb14045

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.